| [1] |
SHE Xinyan, LI Yang, CAI Liting, GUAN Zepu, WANG Xiaohua, JIN Xixi.
Adalimumab in the treatment of 5 cases with folliculitis decalvans and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(9): 639-642.
|
| [2] |
HU Hongxiang, GAO Jingya, ZHOU Xingli, LI Wei.
Guselkumab for the treatment of psoriasis combined with AIDS and hepatitis C: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 276-278.
|
| [3] |
SONG Pingping, WANG Na, DU Donghong, LIU Jing, RAN Delin, YANG Baoqi.
Generalized pustular psoriasis successfully treated with spesolimab: two cases report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(2): 127-129.
|
| [4] |
WU Mingming, WANG Yuan, SUN Ruihan, DU Guiying, CHEN Zhan, PAN Cuicui, WANG Jianqing.
Successful treatment of generalized pustular psoriasis of pregnancy with spesolimab: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 816-818.
|
| [5] |
LI Wenli, YANG Huan.
Biologic therapy for pediatric plaque psoriasis and generalized pustular psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(10): 760-764.
|
| [6] |
ZHANG Meng, SUN Yuexin, LI Zhiyu, BAO Jun, ZHOU Ying.
Acute generalized pustular psoriasis treated with spesolimab: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 37-42.
|
| [7] |
CHEN Jing, XUE Xiaotong, ZHU Li, LIU Hong, ZHANG Furen.
Treatment of perifolliculitis capitis abscedens et suffodiens with TNF-α inhibitors: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 326-329.
|
| [8] |
LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu.
Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
|
| [9] |
SUN Jianlin, HAN Jianwen, WU Riga.
Relapsed and refractory pyoderma gangrenosum treated with a combination of adalimumab and glucocorticoids: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(12): 884-886.
|
| [10] |
DU Baiyinzi, WANG Huiping, LUO Suju.
Efficacy and safety comparation of adalimumab and secukinumab in the treatment of nail psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 26-30.
|
| [11] |
ZHENG Chunzhi, ZHANG Weilin, GUO Xiao, YANG Baoqi, YANG Qing, LIU Hong.
Efficacy and safety of ixekizumab and adalimumab in the treatment of moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 633-638.
|
| [12] |
SANG Xu, WANG Zhenzhen, LI Wenchao, LIU Hong, ZHANG Furen.
Cost-effectiveness analysis of biologic agents in the treatment of moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 344-349.
|
| [13] |
SHI Linli, YAN Shaochen, BI Xinling.
Update of paradoxical reactions induced by commonly used biological agents in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 201-205.
|
| [14] |
ZANG Xiao, LI Hongda, LIU Yongxia, LU Xianmei, YANG Qing, WANG Weiwei, WU Weizhi.
Pyoderma gangrenosum successfully treated with adalimumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 15-17.
|
| [15] |
WANG Youlin, WANG Rui, ZHAO Zhenkai, SUN Jie, ZHANG Yuan, TANG Zijie, ZHANG Han, SHU Xin, LI Chengxin.
Efficacy of adalimumab in the treatment of plaque psoriasis with or without metabolic syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 755-758.
|